TOP2B and glioblastoma: While NCH421k cells were also found to be much more resistant to chemotherapeutics, such as cisplatin and methyl-methanesulfonate, as compared to several established glioblastoma cell lines, the silencing of topoisomerase IIβ expression increased the sensitivity of NCH421k cells to these agents.